• 1
    Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54: 829.
  • 2
    Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328: 136571.
  • 3
    Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348: 146771.
  • 4
    Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348: 14727.
  • 5
    Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137: 13241.
  • 6
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54: 4152.
  • 7
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124: 54460.
  • 8
    Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2003;95: 86877.
  • 9
    American Society for Gastrointestinal Endoscopy. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc. 2000;51: 77782.
  • 10
    Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged > or=50 years—United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52: 1936.
  • 11
    U.S. Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: U.S. Government Printing Office; November 2000.
  • 12
    Knight KK, Fielding JE, Battista RN. U.S. Preventive Services. Task Force Occult blood screening for colorectal cancer. JAMA. 1989;261: 58693.
  • 13
    Ahlquist DA. Occult blood screening. Obstacles to effectiveness. Cancer. 1992;70: 125965.
  • 14
    Wender RC. Barriers to screening for colorectal cancer. Gastrointest Endosc Clin N Am. 2002;12: 14570.
  • 15
    Sharma VK, Vasudeva R, Howden CW. Colorectal cancer screening and surveillance practices by primary care physicians: results of a national survey. Am J Gastroenterol. 2000;95: 15516.
  • 16
    Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89: 140622.
  • 17
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 45781.
  • 18
    Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11: 147.
  • 19
    Powe BD. Perceptions of cancer fatalism among African Americans: the influence of education, income, and cancer knowledge. J Natl Black Nurses Assoc. 1994;7: 418.
  • 20
    DiPalma AM, Barnes SE, DiPalma JA. Patient participation in colon cancer screening programs. South Med J. 1998;91: 3424.
  • 21
    Weitzman ER, Zapka J, Estabrook B, Goins KV. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med. 2001;32: 50213.
  • 22
    Brouse CH, Basch CE, Wolf RL, Shmukler C, Neugut AI, Shea S. Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Public Health. 2003;93: 126871.
  • 23
    Sterchi JM. Screening for colorectal cancer. South Med J. 1979;72: 11446.
  • 24
    Winchester DP, Shull JH, Scanlon EF, et al. A mass screening program for colorectal cancer using chemical testing for occult blood in the stool. Cancer. 1980;45: 29558.
  • 25
    Trehu EG, Cooper JN. Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature. South Med J. 1992;85: 24854.
  • 26
    Khubchandani IT, Karamchandani MC, Kleckner FS, et al. Mass screening for colorectal cancer. Dis Colon Rectum. 1989;32: 7548.
  • 27
    Grazzini G, Castiglione G, Isu A, et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori. 2000;86: 3848.
  • 28
    Ko CW, Dominitz JA, Nguyen TD. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med. 2003;115: 1114.
  • 29
    Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133: 7619.
  • 30
    Weinrich SP, Weinrich MC, Boyd MD, Atwood J, Cervenka B. Teaching older adults by adapting for aging changes. Cancer Nurs. 1994;17: 494500.
  • 31
    Meade CD, McKinney WP, Barnas GP. Educating patients with limited literacy skills: the effectiveness of printed and videotaped materials about colon cancer. Am J Public Health. 1994;84: 11921.
  • 32
    Hart AR, Barone TL, Mayberry JF. Increasing compliance with colorectal cancer screening: the development of effective health education. Health Educ Res. 1997;12: 17180.
  • 33
    Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L. Adherence to continuous screening for colorectal neoplasia. Med Care. 1993;31: 50819.